This statistic represents the medicines in development for selected cancer types in the United States as of late 2020. At this moment, 141 medicines for lung cancer were in development. Thus, lung cancer was the type of cancer with one of the largest numbers of drugs in development.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
PhRMA. (December 14, 2020). Medicines in development for selected cancer types in the United States as of 2020 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 27, 2026, from /statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA. "Medicines in development for selected cancer types in the United States as of 2020." Chart. December 14, 2020. ÌÇÐÄÆƽâ°æ. Accessed July 27, 2026. /statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA. (2020). Medicines in development for selected cancer types in the United States as of 2020. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 27, 2026. /statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA. "Medicines in Development for Selected Cancer Types in The United States as of 2020." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Dec 2020, /statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA, Medicines in development for selected cancer types in the United States as of 2020 ÌÇÐÄÆƽâ°æ, /statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/ (last visited July 27, 2026)
Medicines in development for selected cancer types in the United States as of 2020 [Graph], PhRMA, December 14, 2020. [Online]. Available: /statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
